×
Treatment With Rosuvastatin for Severe Dyslipidemia in Patients With Schizophrenia and Schizoaffective Disorder PDF
$ 40.00
Treatment With Rosuvastatin for Severe Dyslipidemia in Patients With Schizophrenia and Schizoaffective Disorder PDF quantity
$ 40.00
×
Major Changes in Glucose Metabolism, Including New-Onset Diabetes, Within 3 Months After Initiation of or Switch to Atypical Antipsychotic Medication in Patients With Schizophrenia and Schizoaffective Disorder PDF
$ 40.00
Major Changes in Glucose Metabolism, Including New-Onset Diabetes, Within 3 Months After Initiation of or Switch to Atypical Antipsychotic Medication in Patients With Schizophrenia and Schizoaffective Disorder PDF quantity
$ 40.00
×
Evaluation, Treatment, and Referral of Treatment-Resistant Depression in Primary Care PDF
$ 40.00
Evaluation, Treatment, and Referral of Treatment-Resistant Depression in Primary Care PDF quantity
$ 40.00
×
Clinical Predictors of Extrapyramidal Symptoms Associated With Aripiprazole Augmentation for the Treatment of Late-Life Depression in a Randomized Controlled Trial PDF
$ 40.00
Clinical Predictors of Extrapyramidal Symptoms Associated With Aripiprazole Augmentation for the Treatment of Late-Life Depression in a Randomized Controlled Trial PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
